Omar Oakes
May 8, 2018

GSK reviews global media

Pharma giant GlaxoSmithKline has reportedly launched a review of its US $1.8 billion global media agency arrangements, putting MediaCom and PHD on alert.

GSK reviews global media

The review, which is being handled by ID Comms, comes less than three years after GSK awarded its European business to MediaCom, while PHD was handed its US media account.

Both agencies had retained the accounts in 2015 following a global media review, after having been first appointed in 2013.

A year later, GSK completed an agency review for the other parts of its marketing comms business by hiring nine agencies, including Grey and Saatchi & Saatchi for advertising.

GSK's agencies were appointed to work on the company's seven power brands (Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Theraflu and Otrivin) and 12 core brands (Biotene, Contac, Flonase, Excedrin, Fenbid, Tums, ENO, Horlicks, Physiogel, Lamisil, Fenistil and Abreva/Zovirax).

GSK did not respond to a request for comment by Campaign UK by press time while MediaCom and PHD would not comment and referred Campaign to GSK.

Source:
Campaign UK

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

Jan 29, 2026

Gemini 3 becomes the default model for AI Overviews

A pair of updates from Google see the tech giant attempt to gain a further foothold in the battle for AI-powered search supremacy.

Jan 29, 2026

Google criticised after blocking measurement ...

YouTube owner sent a 'cease and desist' letter to Barb and Kantar Media.

Jan 29, 2026

Inside Campaign Connect Indonesia: what matters to ...

Candid conversations on growth, AI and the cultural trade-offs of scaling brands, with more than 100 marketers in the room.

Jan 29, 2026

Meta hits $200 billion revenue milestone on ...

Meta reports double‑digit year-on-year revenue growth, with advertising once again accounting for almost all of the top line.